반응식
[C:1]([C:4]1[CH:9]=[CH:8][N:7]=[CH:6][CH:5]=1)(=[O:3])[CH3:2].[C:10]([O:14][C:15]([N:17]1[CH2:22][CH2:21][CH:20]([O:23][CH2:24][C:25](O)=[O:26])[CH2:19][CH2:18]1)=[O:16])([CH3:13])([CH3:12])[CH3:11]>>[C:10]([O:14][C:15]([N:17]1[CH2:18][CH2:19][CH:20]([O:23][CH2:24][C:25](=[O:26])[CH2:2][C:1](=[O:3])[C:4]2[CH:9]=[CH:8][N:7]=[CH:6][CH:5]=2)[CH2:21][CH2:22]1)=[O:16])([CH3:13])([CH3:12])[CH3:11]참가 물질
3
실험 절차
Condensation of 4-acetylpyridine with 4-carboxymethoxypiperidine-1-carboxylic acid tert-butyl ester (Preparation 1), employing the protocol described in Preparation 22, afforded the title compound: m/z (ES+)=263.2 [M-Boc+H]+.
후처리
- customdescribed in Preparation 22
출처 및 근거
- ORD 기록
- ord-4722c3c8e618440fbf5e176229b823ec
- 출처 데이터셋
- uspto-grants-2012_06
- 특허 번호
- US08207147B2
연결된 노트
불러오는 중…